STOCK TITAN

Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Akebia Therapeutics announced that its CEO, John Butler, will present at the Jefferies Global Healthcare Conference on June 5, 2024, at 9:00 a.m. ET. The conference will be held in New York from June 4-6, 2024. The presentation will be accessible through a webcast on Akebia's investor website for 30 days post-event.

Positive
  • CEO John Butler's participation in a major healthcare conference could enhance visibility for Akebia (AKBA).
  • The webcast availability extends the reach of Akebia's presentation beyond the conference attendees.
Negative
  • The press release does not mention any new product launches, clinical trial results, or financial updates, which could disappoint investors looking for substantive progress.
  • The 30-day webcast access may restrict long-term investor engagement.

CAMBRIDGE, Mass., May 23, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Wednesday, June 5 at 9:00 a.m. ET.

The Jefferies Global Healthcare Conference will take place in New York, NY on June 4-6, 2024.

A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 30 days following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-jefferies-global-healthcare-conference-302153546.html

SOURCE Akebia Therapeutics, Inc.

FAQ

When will Akebia Therapeutics present at the Jefferies Global Healthcare Conference?

On June 5, 2024, at 9:00 a.m. ET.

Where is the Jefferies Global Healthcare Conference held?

In New York, NY, from June 4-6, 2024.

How can investors access Akebia's presentation?

Through a webcast on Akebia's investor website for 30 days following the conference.

What is Akebia Therapeutics' stock symbol?

AKBA.

Akebia Therapeutics, Inc.

NASDAQ:AKBA

AKBA Rankings

AKBA Latest News

AKBA Stock Data

232.65M
188.22M
2.47%
26.27%
6.4%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
CAMBRIDGE

About AKBA

akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients. akebia’s global phase 3 program for vadadustat, which includes the pro2tect studies for non-dialysis patients with anemia associated with chronic kidney disease and the inno2vate studies for dialysis-dependent patients, is currently ongoing. for more information, please visit our website at www.akebia.com.